A Study In Adults With Moderate To Severe Dermatomyositis

Status:
Recruiting

Trial end date:
2022-09-07

Target enrollment:

Participant gender:

A Study looking at Investigational drug and Placebo administered to adult Patients with moderate to severe Dermatomyositis

Phase 2

Pfizer